Research
& Development
FARMAK excels in developing pharmaceutical products across various therapeutic areas. Our extensive capabilities encompass the creation of new products, along with proficiency in validation, stability assessment, documentation, and transfers.
0
Intricate medicines
in pipeline
0
New launches
every year
0 +
R&D
laboratories
$0M
Aprox. annual R&D investment
R&D complex comprises 12 laboratories and 1 pilot site, featuring specialized units. Currently, we are advancing the development of around 100 complex medications, launching up to 20 new drugs annually.
Bringing innovations
to life
FARMAK’s R&D capabilities covering the entire product development lifecycle. This includes advanced formulation, manufacturing processes, and detailed analytical procedures for a variety of release forms. Our approach combines reliability with innovation, ensuring we deliver trustworthy and effective healthcare solutions.
Simple oral dosage forms
- Immediate release tablets
- Orodispersible and chewable tablets
- Oral solutions
- Suspensions
Complex solid dosage forms
- Extended-Release products
- Multilayer tablets
- Multiparticulate system
- Soft gelatin capsules
Transdermal formulations
- Ointments
- Gels
Simple sterile liquids
- Vials
- Ampoules
- Pre-filled syringes
Complex injectables
- Lyophilized
- Extended-release injectables/Injectable suspensions
- Non-aqueous formulations
- Emulsions
- Validation of manufacturing and analytical procedures/methods,
- Stability testing and execution of official stability batches,
- Documentation generation required for drug product registration.
Seamless project transfers to TechTransfer Centers and Contract Manufacturing Organizations (CMOs)
R&D
Centers
